| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.093 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.064 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |